Market Cap
₹14,481 Cr.
P/E
103.95
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

1 No Data

Insufficient data to analyse

ROE
Latest
16.87%
3yr Average
16.45%
5yr Average
17.46%
Net Profit Margin
Latest
9.9%
3yr Average
9.67%
5yr Average
9.03%
ROCE
Latest
26.6%
3yr Average
22.19%
5yr Average
23.44%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Market Share
1.42% (as of Jul 22)
Anti - Diabetes - Market Share
0% (as of Jul 22)
Anti-Infectives - Market Share
1.71% (as of Nov 21)
Antineo Plastic - Market Share
0.56% (as of May 19)
Blood Related - Market Share
1.73% (as of Jul 22)
Cardiovascular - Market Share
0.94% (as of Nov 21)
Endocrinology - Market Share
0% (as of Jul 22)
Gastro-Intestinal - Market Share
0.45% (as of Jul 22)
Pharmaceutical Sector - Market Share
0.11% (as of Nov 21)
Respiratory - Market Share
1.96% (as of May 19)
Stomatological - Market Share
0% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

locked
Source
|
Latest
|
locked
Historic

Dosage Form Break-Up

locked
Source
|
Latest
|
locked
Historic

Brand Wise Break-Up -Oncology

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Crestor
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis